Xenix Medical has obtained US Food and Drug Administration (FDA) clearance for its Lux expandable lumber interbody fusion system and announced the product’s launch on the US market.

Lux is comprised of Xenix’s NeoWave matrix spacer implants and NanoActiv technology. The former is designed to mimic the structure of natural bone to encourage bone growth and reduce the implant’s risk of sinking into the vertebrae, while the latter’s surfacing technology is intended to ensure that implants remain in placed once fitted.